These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3534821)

  • 1. [Evaluation of the clinical usefulness of molsidomine in ischemic heart disease].
    Janicki K; Ochmański W; Kmieć M
    Pol Tyg Lek; 1986 Jun 23-30; 41(25-26):829-34. PubMed ID: 3534821
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of molsidomine on the conjunctival microcirculation in patients with ischemic heart disease].
    Brovko EA; Denisiuk VI; Kolesnik PF
    Vrach Delo; 1989 Nov; (11):49-51. PubMed ID: 2609586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of stress-induced angina pectoris and chronic heart failure with molsidomine].
    Beyerle A; Rudolph W
    Med Klin (Munich); 1986 Jan; 81(2):41-4. PubMed ID: 3537664
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molsidomine in the treatment of ischemic heart disease].
    Sterkowicz S
    Wiad Lek; 1987 Oct; 40(20):1389-95. PubMed ID: 3328427
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute and long-term effects of placebo and molsidomine on pulmonary artery pressure and on workload in patients with coronary heart disease].
    Jansen W; Osterspey A; Schell U; Tauchert M
    Schweiz Rundsch Med Prax; 1986 Oct; 75(41):1210-4. PubMed ID: 3787007
    [No Abstract]   [Full Text] [Related]  

  • 6. [Molsidomine in rest and exercise conditions in coronary heart disease. Acute and long-term effects].
    Jansen W; Meyer L; Osterspey A; Eggeling T; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Jun; 81(14):489-95. PubMed ID: 3097469
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of molsidomine in patients with coronary disease].
    Goch JH; Rosiek S; Brzozowski R; Bała T; Tkaczewski W; Adamska-Dyniewska H
    Pol Tyg Lek; 1985 Jul; 40(29):829-31. PubMed ID: 3903695
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biorhythm influence on the course of ischemic heart disease during combined treatment with molsidomine and anaprilin].
    Vakaliuk IP
    Ter Arkh; 1986; 58(12):49-50. PubMed ID: 3824212
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibition of thrombocyte function in coronary heart disease. Results with molsidomine (Corvaton)].
    Z Kardiol; 1991; 80 Suppl 5():1-70. PubMed ID: 1776328
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemodynamic effect of molsidomine in coronary patients with heart failure with clinically manifest nitrate tolerance].
    Störk T; Möckel M; Störk S; Piske G; Danne O; Bodemann T; Müller R; Eichstädt H; Hochrein H
    Z Kardiol; 1993 May; 82(5):293-301. PubMed ID: 8328179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of Lopion (molsidomine) in the therapy of myocardial ischemia and angina pectoris].
    Trifunović S; Pavlović K
    Med Pregl; 1987; 40(1-2):17-21. PubMed ID: 3657717
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of molsidomin in ischemic cardiopathy].
    Di Giacomo G; Nicolella U; Puligheddu M; Tripodi A; D'Ascoli C; Di Virgilio D
    Clin Ter; 1984 Oct; 111(2):141-6. PubMed ID: 6239736
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute hemodynamic effects of molsidomine in patients with ischemic cardiomyopathy.
    Caralis DG; Kyriakides Z; Ioakimides C
    Cardiovasc Drugs Ther; 1991 Feb; 5(1):155-6. PubMed ID: 2036334
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV
    Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems in long-term therapy of coronary heart disease: pharmacotherapy].
    Gilfrich HJ
    Med Klin (Munich); 1987 Jan; 1():29-32. PubMed ID: 3106752
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of myocardial ischemia with molsidomine].
    Dirschinger J; Beyerle A; Rudolph W
    Med Klin (Munich); 1990 Mar; 85(3):141-4. PubMed ID: 2186260
    [No Abstract]   [Full Text] [Related]  

  • 19. [Carbochromene in ischemic heart disease].
    Maresca FS; De Luca A
    Minerva Cardioangiol; 1973 May; 21(5):386-9. PubMed ID: 4575717
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of molsidomine preparations on the coronary and myocardial reserves of patients with IHD complicated by circulatory failure].
    Ol'binskaia LI; Sizova ZhM; Alekperov EE
    Ter Arkh; 1994; 66(8):30-2. PubMed ID: 7985149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.